Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2016 1
2019 14
2020 61
2021 42
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

113 results
Results by year
Filters applied: . Clear all
Page 1
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.
Bargagli E, Refini RM, d'Alessandro M, Bergantini L, Cameli P, Vantaggiato L, Bini L, Landi C. Bargagli E, et al. Among authors: cameli p. Int J Mol Sci. 2020 Aug 7;21(16):5663. doi: 10.3390/ijms21165663. Int J Mol Sci. 2020. PMID: 32784632 Free PMC article. Review.
Effects of rituximab therapy on B cell differentiation and depletion.
Bergantini L, d'Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, Sestini P, Frediani B, Bargagli E. Bergantini L, et al. Among authors: cameli p. Clin Rheumatol. 2020 May;39(5):1415-1421. doi: 10.1007/s10067-020-04996-7. Epub 2020 Feb 22. Clin Rheumatol. 2020. PMID: 32088800 Review.
Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
d'Alessandro M, Cameli P, Refini RM, Bergantini L, Alonzi V, Lanzarone N, Bennett D, Rana GD, Montagnani F, Scolletta S, Franchi F, Frediani B, Valente S, Mazzei MA, Bonella F, Bargagli E. d'Alessandro M, et al. Among authors: cameli p. J Med Virol. 2020 Oct;92(10):2216-2220. doi: 10.1002/jmv.26087. Epub 2020 Jun 9. J Med Virol. 2020. PMID: 32470148 Free PMC article.
Immunologic responses to antifibrotic treatment in IPF patients.
d'Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, Refini RM, Alonzi V, Sestini P, Bargagli E. d'Alessandro M, et al. Among authors: cameli p. Int Immunopharmacol. 2021 Jun;95:107525. doi: 10.1016/j.intimp.2021.107525. Epub 2021 Mar 11. Int Immunopharmacol. 2021. PMID: 33714885
Serial KL-6 measurements in COVID-19 patients.
d'Alessandro M, Bergantini L, Cameli P, Curatola G, Remediani L, Bennett D, Bianchi F, Perillo F, Volterrani L, Mazzei MA, Bargagli E; Siena COVID. d'Alessandro M, et al. Among authors: cameli p. Intern Emerg Med. 2021 Sep;16(6):1541-1545. doi: 10.1007/s11739-020-02614-7. Epub 2021 Jan 16. Intern Emerg Med. 2021. PMID: 33453011 Free PMC article.
Prognostic bioindicators in severe COVID-19 patients.
Bergantini L, Bargagli E, d'Alessandro M, Refini RM, Cameli P, Galasso L, Scapellato C, Montagnani F, Scolletta S, Franchi F, Valente S, Bennett D, Sebastiani G, Frediani B, Dotta F. Bergantini L, et al. Among authors: cameli p. Cytokine. 2021 May;141:155455. doi: 10.1016/j.cyto.2021.155455. Epub 2021 Jan 28. Cytokine. 2021. PMID: 33548798 Free PMC article.
Clinical phenotyping in sarcoidosis management.
Rana GD, d'Alessandro M, Rizzi L, Bergantini L, Cameli P, Vozza A, Sestini P, Suppressa P, Bargagli E. Rana GD, et al. Among authors: cameli p. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021007. doi: 10.36141/svdld.v38i2.10423. Epub 2021 Jun 28. Sarcoidosis Vasc Diffuse Lung Dis. 2021. PMID: 34316252 Free PMC article.
Prognostic role of KL-6 in lymphangioleiomyomatosis patients.
D'Alessandro M, Bergantini L, Cameli P, Perillo F, Remediani L, Refini RM, Pieroni M, Mazzei MA, Sestini P, Bargagli E. D'Alessandro M, et al. Among authors: cameli p. Minerva Med. 2021 Feb 12. doi: 10.23736/S0026-4806.21.07322-5. Online ahead of print. Minerva Med. 2021. PMID: 33576198 No abstract available.
113 results